Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome

References

1. 1.↵
   1. Calabrese LH,
   2. Dodick DW,
   3. Schwedt TJ, et al

   . Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007;146:34–44 doi:10.7326/0003-4819-146-1-200701020-00007 pmid:17200220

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Miller TR,
   2. Shivashankar R,
   3. Mossa-Basha M, et al

   . Reversible cerebral vasoconstriction syndrome, Part 2: diagnostic work-up, imaging evaluation, and differential diagnosis. AJNR Am J Neuroradiol 2015;36:1580–88 doi:10.3174/ajnr.A4215 pmid:25614476

   Abstract/FREE Full Text
3. 3.↵
   1. Singhal AB,
   2. Hajj-Ali RA,
   3. Topcuoglu MA, et al

   . Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011;68:1005–12 doi:10.1001/archneurol.2011.68 pmid:21482916

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Ducros A

   . Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906–17 doi:10.1016/S1474-4422(12)70135-7 pmid:22995694

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Ducros A,
   2. Boukobza M,
   3. Porcher R, et al

   . The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome: a prospective series of 67 patients. Brain 2007;130:3091–101 doi:10.1093/brain/awm256 pmid:18025032

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Kadkhodayan Y,
   2. Alreshaid A,
   3. Moran CJ, et al

   . Primary angiitis of the central nervous system at conventional angiography. Radiology 2004;233:878–82 doi:10.1148/radiol.2333031621 pmid:15498898

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Singhal AB,
   2. Topcuoglu MA

   . Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology 2017;88:228–36 doi:10.1212/WNL.0000000000003510 pmid:27940651

   Abstract/FREE Full Text
8. 8.↵
   1. Singhal AB,
   2. Topcuoglu MA,
   3. Fok JW, et al

   . Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison. Ann Neurol 2016;79:882–94 doi:10.1002/ana.24652 pmid:27043703

   CrossRefPubMed
9. 9.↵
   1. Rocha EA,
   2. Topcuoglu MA,
   3. Silva GS, et al

   . RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome. Neurology 2019;92:e639–47 doi:10.1212/WNL.0000000000006917 pmid:30635475

   Abstract/FREE Full Text
10. 10.↵
    1. Crockett MT,
    2. Di Loreto M,
    3. Philips TJ

    . Severe reversible cerebral vasoconstriction syndrome in a postpartum patient treated successfully with direct instillation of intra-arterial verapamil during cerebral angiography. J Vasc Interv Neurol 2017;9:43–44 pmid:29445439

    PubMed
11. 11.↵
    1. Elstner M,
    2. Linn J,
    3. Muller-Schunk S, et al

    . Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine. Cephalalgia 2009;29:677–82 doi:10.1111/j.1468-2982.2008.01768.x pmid:19239677

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Farid H,
    2. Tatum JK,
    3. Wong C, et al

    . Reversible cerebral vasoconstriction syndrome: treatment with combined intra-arterial verapamil infusion and intracranial angioplasty. AJNR Am J Neuroradiol 2011;32:E184–87 doi:10.3174/ajnr.A2341 pmid:21273351

    Abstract/FREE Full Text
13. 13.↵
    1. French KF,
    2. Hoesch RE,
    3. Allred J, et al

    . Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome. J Clin Neurosci 2012;19:174–76 doi:10.1016/j.jocn.2011.06.016 pmid:22118796

    CrossRefPubMed
14. 14.↵
    1. Ioannidis I,
    2. Nasis N,
    3. Agianniotaki A, et al

    . Reversible cerebral vasoconstriction syndrome: treatment with multiple sessions of intra-arterial nimodipine and angioplasty. Interv Neuroradiol 2012;18:297–302 doi:10.1177/159101991201800308 pmid:22958768

    CrossRefPubMed
15. 15.↵
    1. John S,
    2. Donnelly M,
    3. Uchino K

    . Catastrophic reversible cerebral vasoconstriction syndrome associated with serotonin syndrome. Headache 2013;53:1482–87 doi:10.1111/head.12202 pmid:24001215

    CrossRefPubMed
16. 16.↵
    1. Kass-Hout T,
    2. Kass-Hout O,
    3. Sun CH, et al

    . A novel approach to diagnose reversible cerebral vasoconstriction syndrome: a case series. J Stroke Cerebrovasc Dis 2015;24:e31–37 doi:10.1016/j.jstrokecerebrovasdis.2014.08.023 pmid:25440342

    CrossRefPubMed
17. 17.↵
    1. Linn J,
    2. Fesl G,
    3. Ottomeyer C, et al

    . Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases? Cephalalgia 2011;31:1074–81 doi:10.1177/0333102410394673 pmid:21220377

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Ospel JM,
    2. Wright CH,
    3. Jung R, et al

    . Intra-arterial verapamil treatment in oral therapy-refractory reversible cerebral vasoconstriction syndrome. AJNR Am J Neuroradiol 2020;41:293–99 doi:10.3174/ajnr.A6378 pmid:31879333

    Abstract/FREE Full Text
19. 19.↵
    1. Milburn JM,
    2. Moran CJ,
    3. Cross DT, et al

    . Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 1998;88:38–42 doi:10.3171/jns.1998.88.1.0038 pmid:9420070

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Wolff V,
    2. Ducros A

    . Reversible cerebral vasoconstriction syndrome without typical thunderclap headache. Headache 2016;56:674–87 doi:10.1111/head.12794 pmid:27016378

    CrossRefPubMed
21. 21.↵
    1. Caria F,
    2. Zedde M,
    3. Gamba M, et al

    ; Italian Project on Stroke at Young Age (IPSYS) Investigators. The clinical spectrum of reversible cerebral vasoconstriction syndrome: the Italian Project on Stroke at Young Age (IPSYS). Cephalalgia 2019;39:1267–76 doi:10.1177/0333102419849013 pmid:31060368

    CrossRefPubMed
22. 22.↵
    1. Al-Mufti F,
    2. Dodson V,
    3. Wajswol E, et al

    . Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome. Br J Neurosurg 2018;32:431–35 doi:10.1080/02688697.2018.1479512 pmid:30207193

    CrossRefPubMed
23. 23.↵
    1. Bouchard M,
    2. Verreault S,
    3. Gariepy JL, et al

    . Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome. Headache 2009;49:142–45 doi:10.1111/j.1526-4610.2008.01211.x pmid:18647181

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Laneuville M,
    2. Ding J,
    3. Shamy M, et al

    . Intra-arterial milrinone may differentiate fulminant RCVS from vasculitis. Neurology 2017;89:1093–94 doi:10.1212/WNL.0000000000004337 pmid:28871063

    Abstract/FREE Full Text
25. 25.↵
    1. Ducros A,
    2. Bousser MG

    . Reversible cerebral vasoconstriction syndrome. Pract Neurol 2009;9:256–67 doi:10.1136/jnnp.2009.187856 pmid:19762885

    Abstract/FREE Full Text
26. 26.↵
    1. Ghia D,
    2. Cuganesan R,
    3. Cappelen-Smith C

    . Delayed angiographic changes in postpartum cerebral angiopathy. J Clin Neurosci 2011;18:435–36 doi:10.1016/j.jocn.2010.07.103 pmid:21237651

    CrossRefPubMed
27. 27.↵
    1. Ducros A,
    2. Wolff V

    . The typical thunderclap headache of reversible cerebral vasoconstriction syndrome and its various triggers. Headache 2016;56:657–73 doi:10.1111/head.12797 pmid:27015869

    CrossRefPubMed
28. 28.↵
    1. Hartung MP,
    2. Grist TM,
    3. François CJ

    . Magnetic resonance angiography: current status and future directions. J Cardiovasc Magn Reson 2011;13:19 doi:10.1186/1532-429X-13-19 pmid:21388544

    CrossRefPubMed
29. 29.↵
    1. Turan N,
    2. Heider RA,
    3. Roy AK, et al

    . Current perspectives in imaging modalities for the assessment of unruptured intracranial aneurysms: a comparative analysis and review. World Neurosurg 2018;113:280–92 doi:10.1016/j.wneu.2018.01.054 pmid:29360591

    CrossRefPubMed
30. 30.↵
    1. Tan LH,
    2. Flower O

    . Reversible cerebral vasoconstriction syndrome: an important cause of acute severe headache. Emerg Med Int 2012;2012:303152 doi:10.1155/2012/303152 pmid:22830030

    CrossRefPubMed
31. 31.↵
    1. Miller TR,
    2. Shivashankar R,
    3. Mossa-Basha M, et al

    . Reversible cerebral vasoconstriction syndrome, Part 1: epidemiology, pathogenesis, and clinical course. AJNR Am J Neuroradiol 2015;36:1392–99 doi:10.3174/ajnr.A4214 pmid:25593203

    Abstract/FREE Full Text
32. 32.↵
    1. Hosny A,
    2. Parmar C,
    3. Quackenbush J, et al

    . Artificial intellience in radiology. Nat Rev Cancer 2018;18:500–10 doi:10.1038/s41568-018-0016-5 pmid:29777175

    CrossRefPubMed